NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants
In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available
Joseph Cullen, Cancer Prevention Leader, Dead At 54
‘Major Discover’ At FCRDC Is NF1 Gene, Report Says
DCT Advisors Reject MRS Concept, Approve RDOG Expansion
DCT Board Approves Drug Development Recompetition
Trending Stories
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Senate Finance Committee advances RFK Jr. to likely confirmation, with Bill Cassidy (R-LA) casting the deciding vote
- “Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender
Medical group sues over removing “information used every day by health professions” - Tracking Trump’s early impact on cancer policy
Research and care disrupted, NCI programs face unpredictable future - Beyond the $500B Stargate Project: The frontier of AI in oncology beckons